CIRRHOSIS ALCOHOLIC

Clinical trials for CIRRHOSIS ALCOHOLIC explained in plain language.

Never miss a new study

Get alerted when new CIRRHOSIS ALCOHOLIC trials appear

Sign up with your email to follow new studies for CIRRHOSIS ALCOHOLIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Common heart drug may hold key to slowing deadly liver disease

Disease control Recruiting now

This study is testing whether a cholesterol-lowering drug called rosuvastatin can safely slow the progression of liver cirrhosis. It will involve about 256 adults with early-stage cirrhosis who are not yet experiencing severe complications. Participants will take either the drug …

Matched conditions: CIRRHOSIS ALCOHOLIC

Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

CIRRHOSIS ALCOHOLIC

Get alerted when new CIRRHOSIS ALCOHOLIC trials appear

Common heart drug may hold key to slowing deadly liver disease